home / United States / AIM ImmunoTech

AIM ImmunoTech Market Cap

$14.35 M

+363,541 Dollars

AMEX:AIM · January 23, 2025

Share price

$0.22

Enterprise Value

$6.04 M

Change (1-Year)

-47.5%

Global Rank

#8734

Country Rank

#3450

Regions

USA

Market cap

As of January 23, 2025, AIM ImmunoTech (AIM) has a market cap of $14.350 million USD. According to our data, AIM ImmunoTech is ranked No.8734 in global market value.

Sector Rank:

Biotech #740 Pharmaceuticals #671

AIM Market Capitalization Growth

30D Growth:

5.0%

1 Years Growth:

-47.5%

3 Years Growth:

-73.4%

5 Years Growth:

-81.6%

10 Years Growth:

-99.8%

15 Years Growth:

-99.9%

20 Years Growth:

-100.0%

Total Growth:

-99%

AIM ImmunoTech Market Cap Chart

YTD

10Y

15Y

20Y

MAX

AIM ImmunoTech Market Cap CAGR Chart

AIM ImmunoTech Market Cap History 1996 - 2025

Year	Market Cap	%Change
Jan 23, 2025	$14.35 M	12.50%
Dec 31, 2024	$12.76 M	-54.55%
Dec 29, 2023	$28.06 M	41.94%
Dec 30, 2022	$19.77 M	-66.30%
Dec 31, 2021	$58.68 M	-48.60%
Dec 31, 2020	$0.11 B	231.48%
Dec 31, 2019	$34.44 M	-93.18%
Dec 31, 2018	$0.51 B	-48.57%
Dec 29, 2017	$0.98 B	-49.28%
Dec 30, 2016	$1.94 B	-28.13%
Dec 31, 2015	$2.69 B	-68.00%
Dec 31, 2014	$8.42 B	-7.41%
Dec 31, 2013	$9.09 B	8.00%
Dec 31, 2012	$8.42 B	25.00%
Dec 30, 2011	$6.74 B	-59.18%
Dec 31, 2010	$16.50 B	-12.50%
Dec 31, 2009	$18.86 B	55.56%
Dec 31, 2008	$12.12 B	-52.63%
Dec 31, 2007	$25.59 B	-65.45%
Dec 29, 2006	$74.09 B	1.38%
Dec 30, 2005	$73.08 B	14.21%
Dec 31, 2004	$63.98 B	-15.93%
Dec 31, 2003	$76.11 B	6.10%
Dec 31, 2002	$71.73 B	-52.67%
Dec 31, 2001	$151.54 B	-5.26%
Dec 29, 2000	$159.96 B	-52.20%
Dec 31, 1999	$334.65 B	44.55%
Dec 31, 1998	$231.52 B	69.23%
Dec 31, 1997	$136.81 B	80.56%
Dec 31, 1996	$75.77 B	100%

Similar Companies to AIM ImmunoTech

Name	Market Cap	Market cap difference	Regions
Vir Biotechnology VIR	$1.45 B	0.000 M	USA
Inovio Pharmaceuticals INO	$81.23 M	0.000 M	USA
Novavax NVAX	$1.41 B	-0.000 M	USA
Vaxart VXRT	$0.19 B	-0.000 M	USA
BioNTech BNTX	$27.61 B	0.000 M	Germany
Moderna MRNA	$14.82 B	-0.000 M	USA
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Pfizer PFE	$147.40 B	-0.003 M	USA
Johnson & Johnson JNJ	$349.75 B	0.001 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
GlaxoSmithKline GSK	$68.21 B	-0.002 M	UK
Sanofi SNY	$129.14 B	0.001 M	France
Merck MRK	$242.04 B	-0.000 M	USA

About AIM ImmunoTech Inc.

Name

AIM ImmunoTech Inc.

Website

https://aimimmuno.com

Headquarters

Ocala,FL

symbol

AIM

CURRENCY

USD

country

United States

fullTimeEmployees

exchange

ASE

firstTradeDateEpochUtc

1996/07/12

AIM Market Cap Formula

Market Cap	=	AIM Stock Price	*	AIM Shares Outstanding
	=	$0.22	*	63.78 M
	=	$14.35 M

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe